Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications. [PDF]
Marafioti M +12 more
europepmc +1 more source
We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth +17 more
wiley +1 more source
Correction to "Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer". [PDF]
europepmc +1 more source
Clinical Utility of Germline Whole-Exome Sequencing Beyond Multigene Panels in Hereditary Cancer. [PDF]
Dell'Elice A +16 more
europepmc +1 more source
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu +9 more
wiley +1 more source
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso +5 more
wiley +1 more source
Inhibitory effects of c-MYC degrading rLON protease on intestinal polyps in PIRC rat, a familial adenomatous polyposis model. [PDF]
Venkatachalam K +8 more
europepmc +1 more source
PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer. [PDF]
Cybulski C +12 more
europepmc +1 more source
A Qualitative Study of Family Centrality in Modified Dignity Therapy Experiences Among Korean Patients With Advanced Cancer: KCSG-PC22-10. [PDF]
Park SR +4 more
europepmc +1 more source
Correction to "Clinical, genetic, and familial features of POT1 tumor predisposition syndrome". [PDF]
europepmc +1 more source

